Fennec Pharmaceuticals (FENC) Change in Inventory (2023 - 2025)
Fennec Pharmaceuticals' (FENC) quarterly Change in Inventory came in at -$139000.0 in Q4 2025, down 113.85% YoY from $1.0 million in Q4 2024, and down 150.36% on a QoQ basis from $276000.0 in Q3 2025.
Fennec Pharmaceuticals (FENC) Change in Inventory (2023 - 2025) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 3 years of Change in Inventory data on file, last reported at -$139000.0 in Q4 2025.
- Quarterly Change in Inventory fell 113.85% year-over-year to -$139000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.3 million (up 320.73% YoY) and the FY2025 annual result came in at $1.3 million, up 320.73% from the prior year.
- Change in Inventory eased to -$139000.0 in Q4 2025, from $276000.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $797000.0 in Q2 2025 to a low of -$502000.0 in Q3 2024.
- A 3-year average of $189916.7 and a median of $296000.0 in 2023 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2024 — Change in Inventory tumbled 258.86% — and 2025, when it surged 896.25%.
- Tracing FENC's Change in Inventory over 3 years: stood at $401000.0 in 2023, then slumped by 116.21% to -$65000.0 in 2024, then sank by 113.85% to -$139000.0 in 2025.
- The last three Change in Inventory figures came in at -$139000.0 (Q4 2025), $276000.0 (Q3 2025), and $797000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -139,000.00 |
| Dec 31, 2025 | -139,000.00 |
| Sep 30, 2025 | 276,000.00 |
| Sep 30, 2025 | 276,000.00 |
| Jun 30, 2025 | 797,000.00 |
| Jun 30, 2025 | 797,000.00 |
| Mar 31, 2025 | 344,000.00 |
| Mar 31, 2025 | 344,000.00 |
| Dec 31, 2024 | -65,000.00 |
| Dec 31, 2024 | -65,000.00 |
| Sep 30, 2024 | -502,000.00 |
| Sep 30, 2024 | -502,000.00 |
| Jun 30, 2024 | 80,000.00 |
| Jun 30, 2024 | 80,000.00 |
| Mar 31, 2024 | -92,000.00 |
| Mar 31, 2024 | -92,000.00 |
| Dec 31, 2023 | 401,000.00 |
| Dec 31, 2023 | 401,000.00 |
| Sep 30, 2023 | 316,000.00 |
| Sep 30, 2023 | 316,000.00 |